Donal Quinn has been appointed new head of the Diagnostics division of the Siemens Healthcare Sector. In his new position, Quinn succeeds Jim Reid-Anderson, who on May 1st became the new CEO of this sector. Prior to his new job, Quinn served as Executive Vice President and Chief Customer Officer of the Diagnostics division since November 2007. More

DEERFIELD, IL., Feb. 18, 2008 ― Siemens Healthcare (www.siemens.com/diagnostics) announced today that its VERSANT™ 440 Molecular System has been approved for marketing by the U.S. Food and Drug Administration (FDA) for use with the VERSANT HCV RNA 3.0 assay for management of HCV-infected patients undergoing antiviral therapy. More

Deerfield, IL, January 16, 2008  Siemens Healthcare Diagnostics, today announced that it has launched the LOCI® Folate, LOCI® B12, and LOCI® Ferritin tests for use on the Dimension Vista® 1500 Intelligent Lab System, an ultra-integrated chemistry analyzer More

DEERFIELD, IL, Dec. 20, 2007 – Siemens Medical Solutions Diagnostics today announced the introduction of the MicroScan® WalkAway® plus Systems for mid- and high-volume clinical diagnostic microbiology laboratories. More

Siemens has successfully completed the acquisition of Dade Behring Holdings, Inc. The laboratory diagnostics company joins the existing business of Siemens Medical Solutions Diagnostics. As the market leader in the attractive and rapidly growing field of in vitro diagnostics, Siemens now can offer its customers a unique and comprehensive healthcare solutions' portfolio, which brings together the entire medical imaging, laboratory diagnostics and clinical information technology (IT) value chain under one roof. More

Siemens Medical Solutions Diagnostics, a leader in the in vitro diagnostic industry, announced that they have signed an agreement with B-R-A-H-M-S Aktiengesellschaft for the rights to develop, produce and distribute a Procalcitonin assay used to assist with the early diagnosis of patients at risk for progression to severe sepsis. More

As the cash tender offer expired at 12:00 midnight on Oct. 31, 2007, Siemens intends to accept all validly tendered shares of U.S.-based laboratory diagnostics company Dade Behring. Siemens expects to close the transaction on or about Nov. 6, 2007. More

TARRYTOWN, NY, October 24, 2007 – Siemens Medical Solutions Diagnostics today announced that the TRUGENE®
HIV-1 Genotyping Kit and OpenGene DNA Sequencing System are now supported by the Apple iMac OSX operating system. The TRUGENE iMac OSX-based system provides an integrated computational system that delivers enhanced data management, simplified system configuration and networking support as well as increased flexibility and throughput for laboratories that provide genotype and gene sequence information. The system is available in Europe, Asia-Pacific, Canada, South America and Latin America as a CE marked product. More

TARRYTOWN, NY, October 4, 2007 – Siemens Medical Solutions Diagnostics, announced today that it has been selected by MedAssets Supply Chain Systems, a Group Purchasing Organization (GPO) and supply chain management company, to provide Chemistry, Automation, and Immunoassay solutions for its facilities. More

Tarrytown, N.Y., October 2, 2007 - Siemens Medical Solutions Diagnostics announced today worldwide availability of version 2.0 software for the Rapidlab 1200® Series Blood Gas System. The new software will be a required upgrade for all existing customers and included on all Rapidlab 1200 systems in the future. More